Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Isavuconazole: Case Report and Review of the Literature | Zendy

Samantha E. Jacobs | Zendy; Deborah Saez-Lacy | Zendy; Walter Wynkoop | Zendy; Thomas J. Walsh | Zendy

Open Access

Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Isavuconazole: Case Report and Review of the Literature

Author(s) -

Samantha E. Jacobs,

Deborah Saez-Lacy,

Walter Wynkoop,

Thomas J. Walsh

Publication year - 2017

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofx040

Subject(s) - allergic bronchopulmonary aspergillosis , medicine , aspergillosis , antifungal , intensive care medicine , pulmonary aspergillosis , adverse effect , dermatology , immunology , immunoglobulin e , antibody

Isavuconazole is a new triazole that is approved for primary therapy of invasive aspergillosis. We provide the first report of a patient with allergic bronchopulmonary aspergillosis (ABPA) who was successfully treated with isavuconazole with marked improvement and minimal adverse effects. We further review the literature on antifungal management of ABPA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research